Dialysis products GranuFlo® and Naturalyte® put patients at high risk of suffering serious, life threatening heart problems.

The U.S. Food and Drug Administration (FDA) has issued a Class 1 Recall of GranuFlo® and Naturalyte® liquid, popular dialysis products manufactured by Fresenius Medical Care. A Class 1 Recall is the FDA’s most serious category and is issued for products that pose risk of serious injury or death. Fresenius Medical Care is the largest operator of dialysis centers in the U.S. and manufacturer of dialysis equipment and products. Both GranuFlo® and Naturalyte® were manufactured January 2008 through June 2012

If you or a loved one has suffered cardiac arrhythmia, cardiopulmonary arrest, heart attack, stroke or death while undergoing dialysis treatment, you could be entitled to compensation in a lawsuit. Contact the law firm of Franklin D. Azar and Associates for a free consultation.

Click here for Granuflo® & Nuralyte® drug information